102 hasil
Menampilkan 1–20 · 2,70 detik · RSS
The Lancet Respiratory Medicine
Scopus
ISSN 2213-2600 · Elsevier BV · 102 artikel di indeks
-
Artikel Jurnal Teks lengkap
Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)
BACKGROUND: Bronchiectasis is a heterogeneous, neglected disease with few multicentre studies exploring the causes, severity, microbiology, and treatment of the disease across Europe. This aim of this study was to describe the clinical characteristics of bronchiectasis and compare between different…
-
Artikel Jurnal Teks lengkap
Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations
-
Artikel Jurnal Teks lengkap
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial
Background Rituximab is often used as rescue therapy in interstitial lung disease (ILD) associated with connective tissue disease (CTD), but has not been studied in clinical trials. This study aimed to assess whether rituximab is superior to cyclophosphamide as a treatment for severe or progressive…
-
Artikel Jurnal Teks lengkap
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
BACKGROUND: No effective pharmacological or non-pharmacological interventions exist for patients with long COVID. We aimed to describe recovery 1 year after hospital discharge for COVID-19, identify factors associated with patient-perceived recovery, and identify potential therapeutic targets by…
-
Artikel Jurnal Teks lengkap
Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study
-
Artikel Jurnal Teks lengkap
Interleukin-6: obstacles to targeting a complex cytokine in critical illness